Company

AdvanCell

Biotechnology Research Sydney, New South Wales, Au 65 employees

Employees: 65
Contacts: 4
Emails: 4
Phones: 2

www.advancell.com.au LinkedIn Crunchbase

AdvanCell Overview

Headquarters: Sydney, New South Wales, Au
Website: www.advancell.com.au
Industry: Biotechnology Research
Employees: 65
Founded: 2019
Funding: 11.3M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Radiopharmaceuticals Radioligand Discovery 212Pb Biotechnology Biopharmaceuticals Changing the Course of Cancer

About AdvanCell

AdvanCell is a clinical stage radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the most significant challenge in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell’s novel drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212Pb, the ideal isotope for Targeted Alpha Therapy. For more information, please visit www.advancell.com.au

AdvanCell Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

AdvanCell Org Chart

Sample employees and titles

Name	Title	Location	Contact
Paola Santoro	Clinical Development and Operations	Reading, Massachusetts, United States	Email
Selvakumar Edwardraja	Protein Design & Engineering	Greater Brisbane Area, Australia	Email Phone
Adrian (Adi) Paterson	Technology and Energy Futures	Miranda, New South Wales, Australia	Email
Jamil M. Beg	Venture Capitalist & Bioentrepreneur	Cambridge, Massachusetts, United States	Email Phone